Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide
- PMID: 2413458
- PMCID: PMC391316
- DOI: 10.1073/pnas.82.20.7091
Discrimination between fibrin and fibrinogen by a monoclonal antibody against a synthetic peptide
Abstract
Circulating soluble fibrin, observed in the blood of patients with ongoing intravascular coagulation, is generated from the plasma protein fibrinogen by the limited proteolytic action of thrombin. We report the production of a monoclonal antibody that discriminates between fibrin and fibrinogen in blood. The synthetic hexapeptide Gly-Pro-Arg-Val-Val-Glu, representing the amino terminus of the alpha chain of human fibrin, was used as immunogen. This hexapeptide is located within the A alpha chain of fibrinogen but becomes the amino terminus of the fibrin alpha chain, after fibrinopeptide A is removed by the action of thrombin, and thus becomes accessible for antibody binding. The monoclonal antibody we have prepared can discriminate between fibrin and fibrinogen and thus can be used in assay systems to quantitate soluble fibrin or, potentially, to image fibrin-rich thrombi.
Similar articles
-
A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.Clin Chim Acta. 2002 Apr;318(1-2):25-32. doi: 10.1016/s0009-8981(01)00779-3. Clin Chim Acta. 2002. PMID: 11880109
-
Characterization of a monoclonal antibody specific to the amino terminus of the alpha-chain of human fibrin.Thromb Haemost. 1990 Jun 28;63(3):445-8. Thromb Haemost. 1990. PMID: 2402748
-
The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.Thromb Res. 2007;121(3):377-85. doi: 10.1016/j.thromres.2007.05.008. Epub 2007 Jun 11. Thromb Res. 2007. PMID: 17561232
-
The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.Thromb Haemost. 1999 Aug;82(2):673-83. Thromb Haemost. 1999. PMID: 10605767 Review.
-
Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.Biotechnology. 1991;19:281-313. doi: 10.1016/b978-0-7506-9120-8.50017-2. Biotechnology. 1991. PMID: 1723912 Review. No abstract available.
Cited by
-
Generation of an antibody with a designed specificity difference for protein C and activated protein C.J Protein Chem. 1989 Aug;8(4):471-80. doi: 10.1007/BF01026431. J Protein Chem. 1989. PMID: 2803512
-
Discovery of an uncovered region in fibrin clots and its clinical significance.Sci Rep. 2013;3:2604. doi: 10.1038/srep02604. Sci Rep. 2013. PMID: 24008368 Free PMC article.
-
[Diagnosis of disseminated intravascular coagulation: the value of soluble fibrin, D-dimers and fibrin(ogen) split products].Klin Wochenschr. 1989 Aug 1;67(15):764-73. doi: 10.1007/BF01745348. Klin Wochenschr. 1989. PMID: 2770191 German.
-
The evolution of fibrin-specific targeting strategies.J Mater Chem B. 2015 Feb 21;3(7):1177-1186. doi: 10.1039/C4TB01769B. Epub 2015 Jan 13. J Mater Chem B. 2015. PMID: 29416866 Free PMC article.
-
New strategies in the determination of fibrin and fibrin(ogen) derivatives by monoclonal antibodies.Blut. 1988 Nov;57(5):285-91. doi: 10.1007/BF00320354. Blut. 1988. PMID: 3058234 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases